Lee Seeks Increased Competition in Biological Drug Market
July 14, 2023
July 14, 2023
WASHINGTON, July 14 -- Sen. Mike Lee, R-Utah, issued the following news release:
Sens. Mike Lee (R-UT), Ben Ray Lujan (D-NM), Mike Braun (R-IN), and J.D. Vance (R-OH) introduced the Biosimilar Red Tape Elimination Act to increase competition within the biological drug market and increase access to low-cost prescription drugs.
For small-molecule drugs, pharmacists can substitute generics in lieu of their branded counterparts. Access to generics is essential to increasing . . .
Sens. Mike Lee (R-UT), Ben Ray Lujan (D-NM), Mike Braun (R-IN), and J.D. Vance (R-OH) introduced the Biosimilar Red Tape Elimination Act to increase competition within the biological drug market and increase access to low-cost prescription drugs.
For small-molecule drugs, pharmacists can substitute generics in lieu of their branded counterparts. Access to generics is essential to increasing . . .